# Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain

> **NCT00547586** · PHASE2 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 122 (actual)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** N-methylnaltrexone bromide (MOA-728)
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00547586
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2020-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00547586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00547586, "Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00547586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*